Cargando…
Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile Cancer
SIMPLE SUMMARY: Penile cancer is a rare but aggressive malignancy characterized by rapid tumor growth as well as prompt metastasis in groin lymphatics. While localized diseases can be successfully cured by surgery in most cases, no truly effective treatment options have been established for metastat...
Autores principales: | Thomas, Anita, Reetz, Sascha, Stenzel, Philipp, Tagscherer, Katrin, Roth, Wilfried, Schindeldecker, Mario, Michaelis, Martin, Rothweiler, Florian, Cinatl, Jindrich, Cinatl, Jaroslav, Dotzauer, Robert, Vakhrusheva, Olesya, Albersen, Maarten, Macher-Goeppinger, Stephan, Haferkamp, Axel, Juengel, Eva, Neisius, Andreas, Tsaur, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151654/ https://www.ncbi.nlm.nih.gov/pubmed/34066040 http://dx.doi.org/10.3390/cancers13102323 |
Ejemplares similares
-
Value of c-MET and Associated Signaling Elements for Predicting Outcomes and Targeted Therapy in Penile Cancer
por: Thomas, Anita, et al.
Publicado: (2022) -
Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction
por: Zhao, Fuguang, et al.
Publicado: (2020) -
Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis
por: Markowitsch, Sascha D., et al.
Publicado: (2021) -
Increased HRD score in cisplatin resistant penile cancer cells
por: Winkelmann, Ria, et al.
Publicado: (2022) -
Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells
por: Vakhrusheva, Olesya, et al.
Publicado: (2022)